CA3087572C - Composition de conjugue polysaccharide-proteine pneumococcique multivalent - Google Patents

Composition de conjugue polysaccharide-proteine pneumococcique multivalent

Info

Publication number
CA3087572C
CA3087572C CA3087572A CA3087572A CA3087572C CA 3087572 C CA3087572 C CA 3087572C CA 3087572 A CA3087572 A CA 3087572A CA 3087572 A CA3087572 A CA 3087572A CA 3087572 C CA3087572 C CA 3087572C
Authority
CA
Canada
Prior art keywords
serotype
serotypes
vaccine
conjugated
capsular
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
CA3087572A
Other languages
English (en)
Other versions
CA3087572A1 (fr
Inventor
Kyungjun AN
Dongsoo HAM
Hun Kim
Sunghyun Kim
Jinhwan SHIN
Robert Hopfer
Richard D. KENSINGER
Moe KYAW
Philippe Talaga
Original Assignee
SK Bioscience Co Ltd
Sanofi Pasteur Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by SK Bioscience Co Ltd, Sanofi Pasteur Inc filed Critical SK Bioscience Co Ltd
Priority claimed from PCT/US2019/016506 external-priority patent/WO2019152921A1/fr
Publication of CA3087572A1 publication Critical patent/CA3087572A1/fr
Application granted granted Critical
Publication of CA3087572C publication Critical patent/CA3087572C/fr
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Abstract

La présente invention concerne des compositions de conjugué pneumococcique multivalent, à support mixte comprenant 21 conjugués polysaccharide-protéine capsulaire pneumococcique différents, chacun des conjugués comprenant un polysaccharide capsulaire d'un sérotype différent de Streptococcus pneumoniae conjugué à l'anatoxine tétanique (TT) ou à CRM197, les sérotypes de Streptococcus pneumoniae étant choisis parmi 1, 3, 4, 5, 6A, 6B, 7F, 8, 9N, 9V, 10A, 11A, 12F, 14, 15B, 18C, 19A, 19F, 22F, 23F et 33F, les polysaccharides capsulaires de deux sérotypes des sérotypes 1, 3 et 5 étant conjugués à TT et les polysaccharides capsulaires restants étant conjugués à CRM197. L'invention concerne en outre des procédés de production des compositions de conjugué pneumococcique multivalent à support mixte et des procédés d'utilisation de celles-ci pour la prophylaxie d'une infection ou d'une maladie due à Streptococcus pneumoniae chez un sujet.
CA3087572A 2018-02-05 2019-02-04 Composition de conjugue polysaccharide-proteine pneumococcique multivalent Active CA3087572C (fr)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
US201862626482P 2018-02-05 2018-02-05
US62/626,482 2018-02-05
KR20180045246 2018-04-18
KR10-2018-0045246 2018-04-18
PCT/US2019/016506 WO2019152921A1 (fr) 2018-02-05 2019-02-04 Composition de conjugué polysaccharide-protéine pneumococcique multivalent

Publications (2)

Publication Number Publication Date
CA3087572A1 CA3087572A1 (fr) 2019-08-08
CA3087572C true CA3087572C (fr) 2025-09-16

Family

ID=

Similar Documents

Publication Publication Date Title
US12605435B2 (en) Multivalent pneumococcal polysaccharide-protein conjugate composition
AU2019215212B2 (en) Multivalent pneumococcal polysaccharide-protein conjugate composition
US11241489B2 (en) Multivalent pneumococcal polysaccharide-protein conjugate composition
US11224652B2 (en) Multivalent pneumococcal polysaccharide-protein conjugate composition
CA3087572C (fr) Composition de conjugue polysaccharide-proteine pneumococcique multivalent
EA044822B1 (ru) Поливалентная противопневмококковая полисахаридно-белковая конъюгированная композиция
EA044892B1 (ru) Поливалентная противопневмококковая полисахаридно-белковая конъюгированная композиция